The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass

BackgroundThe sivelestat is a neutrophil elastase inhibitor thought to have an effect against acute lung injury (ALI) in patients after scheduled cardiac surgery. However, the beneficial effect of sivelestat in patients undergoing emergent cardiovascular surgery remains unclear. We aim to evaluate t...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Tuo Pan, Tayierjiang Tuoerxun, Xi Chen, Cheng-Jin Yang, Chen-Yu Jiang, Yi-Fan Zhu, Ze-Shi Li, Xin-Yi Jiang, Hai-Tao Zhang, He Zhang, Ya-Peng Wang, Wei Chen, Li-Chong Lu, Min Ge, Yong-Qing Cheng, Dong-Jin Wang, Qing Zhou
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2023-01-01
主題:	sivelestat cardiopulmonary bypass acute lung injury cardiovascular surgery outcomes
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1082830/full